The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Treatment of Antiphospholipid Antibody Syndrome (APS) in Pregnancy: A Randomized Pilot Trial Comparing Low Molecular Weight Heparin to Unfractionated Heparin
Abstract
Objective To compare low molecular weight heparin (LMWH), specifically dalteparin, to unfractionated heparin (UFH) for the treatment of antiphospholipid antibody syndrome (APS) in pregnancy.Methods In a tertiary referral centre, 28 women met the 1999 International Consensus Criteria for APS, based on their obstetrical history and APS serology. The women were randomized, using a random numbers table with blocks of 12, to receive either prophylactic dosing of dalteparin or UFH starting either preconceptionally or early in pregnancy. All women also received low-dose acetylsalicylic acid, started preconceptionally. The primary outcome was a live birth. The secondary outcomes were maternal and fetal complications.Results Of the 14 women who received the LMWH, dalteparin, and the 14 women who received UFH, 1 woman in each group did not conceive. Nine of the 13 women (69%) given dalteparin had a successful pregnancy (95% confidence interval [CI], 39-91%), compared to 4 out of the 13 women (31%) in the UFH group (95% CI, 9-61%). Nine women in total had spinal or epidural anaesthesia, and there were no complications overall.Conclusion Dalteparin may be an effective alternative to UFH for treatment of APS in pregnancy. A multicentre randomized trial is needed to determine benefit-to-risk ratios for the use of dalteparin and UFH to treat this high-risk obstetrical condition. Pharmacokinetic and pharmacodynamic studies are also recommended to maximize therapeutic response and minimize toxicity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two prospective studies and one RCT, however, reported no difference in efficacy and safety between UFH or LMWH when combined with aspirin in the treatment of women with recurrent miscarriage associated with aPL.166,167”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [167]
Citations
Cites
Brandt, J. T., Triplett, D. A., Alving, B. M., & Scharrer, I. (1995) · PubMed · Cited by 1,164
Rai, R., Cohen, H., Dave, M., & Regan, L. (1997) · BMJ · doi:10.1136/bmj.314.7076.253 · Cited by 1,113
Heparin and Low-Molecular-Weight Heparin
Hirsh, J., Warkentin, T. E., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (1998) · Chest · doi:10.1378/chest.114.5_supplement.489s · Cited by 1,031
Brandt, J. T., Triplett, D. A., Alving, B., & Scharrer, I. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649901 · Cited by 993
Kutteh, W. H. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70610-5 · Cited by 803
Frequency of factors associated with habitual abortion in 197 couples
Daya, S., & Stephenson, M. D. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58382-4 · Cited by 428
Self-citationAntiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment
Farquharson, R. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02165-8 · Cited by 427
Harris, E. N. (1990) · American Journal of Clinical Pathology · doi:10.1093/ajcp/94.4.476 · Cited by 414
Rai, R. S., Clifford, K., Cohen, H., & Regan, L. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a135907 · Cited by 301
Nelson-Piercy, C., Letsky, E. A., & de Swiet, M. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70403-4 · Cited by 260
Research works printed but not linked: 1
- 1998, Antiphospholipid syndrome, ACOG Educational Bulletin, 244, 151
Cited by
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525
Ruiz-Irastorza, G., Crowther, M., Branch, W., & Khamashta, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60709-x · Cited by 831
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Pabinger, I., Sofaer, S., & Hirsh, J. (2008) · Chest · doi:10.1378/chest.08-0761 · Cited by 793
Guidelines on the investigation and management of antiphospholipid syndrome
Keeling, D., Mackie, I., Moore, G. W., Greer, I. A., Greaves, M., & British Committee for Standards in Haematology (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09037.x · Cited by 740
“However, in two small pilot studies the combination of LMWH and low dose aspirin appeared equivalent to UFH and low dose aspirin in preventing recurrent pregnancy loss (Stephenson et al, 2004; Noble et al, 2005).”
BackgroundPrevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant
Empson, M. B., Lassere, M., Craig, J. C., & Scott, J. R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002859.pub2 · Cited by 486
Metadata
- Authors
- Stephenson, M. D., Ballem, P. J., Tsang, P., Purkiss, S., Ensworth, S., Houlihan, E., & Ensom, M. H. H.
- Affiliations
- University of British Columbia (CA)
- B.C. Women's Hospital & Health Centre (CA)
- Venue
- Journal of Obstetrics and Gynaecology Canada
- Publisher
- Elsevier BV
- Published
- 2004-08
- Volume
- 26
- Issue
- 8
- Pages
- 729-734
- ISSN
- 1701-2163 (ISSN-L)
- OpenAlex
- W117666081
- Cited by
- 140
- References
- 30
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 2 · 2021: 4 · 2020: 1 · 2019: 7 · 2018: 5 · 2017: 9 · 2016: 2 · 2015: 5 · 2014: 14 · 2013: 9 · 2012: 12
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of Obstetrics and Gynaecology Canada (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of British Columbia
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Health Sciences › Medicine › Hematology › Heparin-Induced Thrombocytopenia and Thrombosis
- Keywords
- antiphospholipid syndrome, pregnancy, dalteparin, low molecular weight heparin, unfractionated heparin, anticoagulation, live birth, aspirin, maternal complications, fetal complications
- MeSH terms
- Adult, Anticoagulants, Aspirin, Female, Heparin, Humans, Pilot Projects, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Antiphospholipid Syndrome, Preconception Care, Dalteparin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Antiphospholipid Antibody Syndrome (APS) in Pregnancy: A Randomized Pilot Trial Comparing Low Molecular Weight Heparin to Unfractionated Heparin. https://app.cochat.ai/papers/10.1016/s1701-2163(16)30644-2
- The paper
- Stephenson, M. D., Ballem, P. J., Tsang, P., Purkiss, S., Ensworth, S., Houlihan, E., & Ensom, M. H. H. (2004). Treatment of Antiphospholipid Antibody Syndrome (APS) in Pregnancy: A Randomized Pilot Trial Comparing Low Molecular Weight Heparin to Unfractionated Heparin. Journal of Obstetrics and Gynaecology Canada. https://doi.org/10.1016/s1701-2163(16)30644-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.